PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer
Ming‐Sound Tsao(University Health Network), Élisabeth Brambilla(Inserm)
Cited by 115
Related Papers
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|479
Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model
|Journal of Thoracic Oncology|2022|61
Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma
|Journal of Thoracic Oncology|2012|56
The <scp>NRF2</scp> antagonist <scp>ML385</scp> inhibits <scp>PI3K‐mTOR</scp> signaling and growth of lung squamous cell carcinoma cells
|Cancer Medicine|2022|45
Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma
|Molecular Cancer|2010|44